A Look At Masimo (MASI) Valuation After Recent Share Price Rebound

Simply Wall St.05-02

AdvertisementMasimo stock snapshot after recent performance shifts Masimo (MASI) has drawn attention after a period where the share price, recent returns and underlying financial results offer a mixed...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2632622747?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","is_english":true,"pubTime":"2026-05-02 13:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2632622747","market":"us","top_or_hot":-1,"title":"A Look At Masimo (MASI) Valuation After Recent Share Price Rebound","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementMasimo stock snapshot after recent performance shifts Masimo (MASI) has drawn attention after a period where the share price, recent returns and underlying financial results offer a mixed...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-masi/masimo/news/a-look-at-masimo-masi-valuation-after-recent-share-price-reb-1\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Masimo (MASI) Valuation After Recent Share Price Rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Masimo (MASI) Valuation After Recent Share Price Rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-02 13:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-masi/masimo/news/a-look-at-masimo-masi-valuation-after-recent-share-price-reb-1><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementMasimo stock snapshot after recent performance shifts Masimo (MASI) has drawn attention after a period where the share price, recent returns and underlying financial results offer a mixed...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-masi/masimo/news/a-look-at-masimo-masi-valuation-after-recent-share-price-reb-1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2764262908.HKD","symbol_name":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (HKD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-masi/masimo/news/a-look-at-masimo-masi-valuation-after-recent-share-price-reb-1","article_id":"2632622747","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-masi/masimo/news/a-look-at-masimo-masi-valuation-after-recent-share-price-reb-1","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2632622747","pubTimestamp":1777700178,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Masimo stock snapshot after recent performance shifts\nMasimo (MASI) has drawn attention after a period where the share price, recent returns and underlying financial results offer a mixed picture for investors assessing this medical technology company.\nSee our latest analysis for Masimo.\nAt a share price of US$178.48, Masimo has seen strong momentum in recent months, with a 90 day share price return of about 30% and a year to date share price return of about 40%. However, the 5 year total...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2764262908.HKD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (HKD) ACC","BK4082":"医疗保健设备","LU0205193047.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","LU0240878834.USD":"SCHRODER ISF GLOBAL SMALL COMPANIES \"A\" (USD) INC AV","LU2764263203.CNY":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (CNYHDG) ACC","LU2720916845.USD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (USD) ACC","LU0240877869.USD":"SCHRODER ISF GLOBAL SMALL COMPANIES \"A\" ACC","LU0205194284.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD) INC AV","MASI":"麦斯莫医疗","LU2764263039.SGD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (SGDHDG) ACC"},"translate_title":"近期股价反弹后马西莫(MASI)估值一览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MASI":1.5},"content_text":"AdvertisementMasimo stock snapshot after recent performance shifts Masimo (MASI) has drawn attention after a period where the share price, recent returns and underlying financial results offer a mixed picture for investors assessing this medical technology company. See our latest analysis for Masimo. At a share price of US$178.48, Masimo has seen strong momentum in recent months, with a 90 day share price return of about 30% and a year to date share price return of about 40%. However, the 5 year total shareholder return is about 20% lower. If Masimo's recent rebound has you rethinking opportunities in healthcare technology, it can be useful to compare it with other names in the sector using a focused screener such as 33 healthcare AI stocks With Masimo trading near its US$180 analyst price target after recent double digit gains, the key question now is whether the current valuation still leaves room for upside or whether the market is already pricing in future growth. Most Popular Narrative: 0.8% Undervalued Masimo's most followed narrative pins fair value at US$180 per share, almost exactly in line with the recent close around US$178, yet it still argues there is a small gap to close.  The expansion of dedicated specialty sales teams and realignment of the commercial structure is expected to drive increased market share in high-growth categories like capnography, brain monitoring, and hemodynamics, where current share is below 20%, which should accelerate top-line revenue growth and elevate long-term earnings.  Read the complete narrative. Curious how this story justifies that price tag? The narrative leans heavily on sustained revenue gains, higher margins and a premium future earnings multiple that is not typical for this sector. Result: Fair Value of $180 (ABOUT RIGHT) Have a read of the narrative in full and understand what's behind the forecasts. However, there is still meaningful deal risk here, including potential regulatory hurdles and tariff or margin pressures that could challenge analysts’ current earnings and valuation assumptions. Find out about the key risks to this Masimo narrative. Another angle on Masimo’s valuation Analysts see Masimo as roughly fairly priced around US$180 based on growth and margin assumptions, but the current 44.9x P/E tells a different story. That multiple is higher than the US Medical Equipment industry at 23.8x and above the 27.5x fair ratio, yet below peers at 69.1x. This raises the question of whether the market is paying up for quality or simply overreaching. For a closer look at how this earnings multiple stacks up against what the numbers suggest the ratio could move toward over time, have a look at the See what the numbers say about this price — find out in our valuation breakdown. NasdaqGS:MASI P/E Ratio as at May 2026Next Steps With sentiment clearly mixed, it helps to look beyond the headlines and check the numbers yourself before forming a view. To weigh up both the upside and the concerns, start by reviewing the 2 key rewards and 1 important warning sign. Looking for more investment ideas? If Masimo has sharpened your focus, do not stop here. Broaden your watchlist with a few targeted sets of stocks that match different goals and risk levels.  Target quality at a discount by scanning 51 high quality undervalued stocks that combine solid fundamentals with prices that may sit below their assessed worth. Prioritise resilience by checking 67 resilient stocks with low risk scores that score well on financial strength and business stability, so surprises are less likely to catch you off guard. Spot underfollowed potential by reviewing the screener containing 25 high quality undiscovered gems that may not yet be widely discussed but still show strong underlying numbers.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2632622747","isCrawlerRequest":true}